{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:38:03Z","timestamp":1762875483457},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.taap.2012.10.024","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T03:32:33Z","timestamp":1352345553000},"page":"245-253","source":"Crossref","is-referenced-by-count":53,"title":["CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid"],"prefix":"10.1016","volume":"266","author":[{"given":"Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.10.024_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.2012.05713.x","article-title":"NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients","volume":"39","author":"An","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.taap.2012.10.024_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid-associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2012.10.024_bb0015","first-page":"224","article-title":"Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection\u2014United States, 2004\u20132008","volume":"59","author":"Centers for Disease, C., and Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.taap.2012.10.024_bb0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mnfr.201100799","article-title":"The effect of taurine on cholesterol metabolism","volume":"56","author":"Chen","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.taap.2012.10.024_bb0025","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.10.024_bb0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1194\/jlr.M800647-JLR200","article-title":"Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation","volume":"50","author":"Cho","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2012.10.024_bb0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2012.07.029","article-title":"Tauro-beta-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential","volume":"424","author":"Denk","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2012.10.024_bb0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/138920007782109760","article-title":"Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(\u2212\/\u2212) mice","volume":"8","author":"Ghanayem","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.taap.2012.10.024_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.106.012492","article-title":"The 2006 Bernard B. Brodie Award Lecture. Cyp2e1","volume":"35","author":"Gonzalez","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.10.024_bb0050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2012.10.024_bb0055","first-page":"1226","article-title":"Antituberculosis drug-induced hepatitis: risk factors, prevention and management","volume":"41","author":"Hussain","year":"2003","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.taap.2012.10.024_bb0060","unstructured":"Kubitz, R., Droge, C., Stindt, J., Weissenberger, K., Haussinger, D., in press. The bile salt export pump (BSEP) in health and disease. Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.taap.2012.10.024_bb0065","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.10.024_bb0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2133\/dmpk.DMPK-11-RG-055","article-title":"Metabolomic analysis reveals novel isoniazid metabolites and hydrazones in human urine","volume":"26","author":"Li","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2012.10.024_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1751-2980.2011.00554.x","article-title":"Liver X receptors bridge hepatic lipid metabolism and inflammation","volume":"13","author":"Liu","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.taap.2012.10.024_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1054\/mehy.1997.0683","article-title":"Pyruvate and hydroxycitrate\/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively \u2018uncoupling\u2019 the oxidation of fatty acids","volume":"52","author":"McCarty","year":"1999","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.taap.2012.10.024_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","article-title":"Phenylalanine hydroxylase deficiency","volume":"13","author":"Mitchell","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.taap.2012.10.024_bb0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jhep.2005.02.028","article-title":"Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid","volume":"43","author":"Perez","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2012.10.024_bb0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-008-0484-8","article-title":"Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil","volume":"64","author":"Possuelo","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2012.10.024_bb0100","unstructured":"Reuter, S.E., Evans, A.M., in press. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2012.10.024_bb9000","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00266958","article-title":"Standardization of biological dyes and stains: pitfalls and possibilities","volume":"95","author":"Schulte","year":"1991","journal-title":"Histochemistry"},{"key":"10.1016\/j.taap.2012.10.024_bb0105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.bjp.0707611","article-title":"Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures","volume":"153","author":"Shen","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.10.024_bb0110","first-page":"803","article-title":"Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients","volume":"25","author":"Sotsuka","year":"2011","journal-title":"In vivo"},{"key":"10.1016\/j.taap.2012.10.024_bb0115","doi-asserted-by":"crossref","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","article-title":"A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels","volume":"294","author":"Stefanovic-Racic","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2012.10.024_bb0120","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.taap.2012.10.024_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile acids as regulators of hepatic lipid and glucose metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.taap.2012.10.024_bb0130","first-page":"51","article-title":"Hydrazine\u2014a possible cause of isoniazid-induced hepatic necrosis","volume":"23","author":"Woo","year":"1992","journal-title":"J. Med."},{"key":"10.1016\/j.taap.2012.10.024_bb0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1476-5381.2009.00173.x","article-title":"Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?","volume":"157","author":"Yue","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.10.024_bb0145","first-page":"699","article-title":"CYP2E1 mediated isoniazid-induced hepatotoxicity in rats","volume":"25","author":"Yue","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2012.10.024_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.phrs.2008.10.006","article-title":"Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats","volume":"59","author":"Yue","year":"2009","journal-title":"Pharmacol. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12004668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T06:58:45Z","timestamp":1562309925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12004668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0041008X12004668"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.10.024","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}